It has been demonstrated that pyruvate dehydrogenase kinase 1 (PDK1) and lysyl oxidase (LOX) were associated with chemoresistance, tumor metastasis, and poor survival (Umezaki et al., 2019; Siu et al., 2020). Here, LOX is linked to neoplasm.